Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 11 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. MCT1 activity defines an aggressive metabolic phenotype and therapeutic target in non-small cell lung cancer
    R. B. Cameron, K. E. Shema, N. Dubois +14
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. Temozolomide-associated inflammatory-repair remodeling in recurrent glioblastoma exposes a ROCK-linked therapeutic vulnerability
    R. Chojak, U. H. Faisal, P. U. Kumthekar +24
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. Clinical, Dermoscopic, and Histopathological Correlation of Pigmented Skin Lesions at a Tertiary Care Dermatology Center.
    Rabia A Ghafoor Sadal, Misbah Salim, Maryam Qayyum +1
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  4. Low-grade myofibroblastic sarcoma of the retroauricular region treated with complete circumferential peripheral and deep margin assessment surgery and local flap construction: A case report
    Laura M. Umaña, María Pineda Muñoz, Hector C. Pérez +3
    JAAD Case ReportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  5. Financial concerns: a critical gap in survivors’ experience of the implementation of the national standards for cancer survivorship care
    Marguerite A. Webster, Abigayle R. Feather, Sandi Back-Haddix +5
    Journal of Cancer SurvivorshipPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  6. Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study
    Takayasu Kurata, Shunichi Sugawara, Hiroaki Akamatsu +17
    International Journal of Clinical OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  7. Noninvasive tomography of tumor progression via dynamical changes of T-cells in surrounding microenvironment
    L. Xu, P. Meng, W. Yin +1
    bioRxivPreprintCC BYFull textOncologybioRxiv
  8. Biomarker-Targeted O6-Guanine Alkylation Potentiates ATR Inhibitor Response in De Novo and Relapsed/Refractory AML
    P. Bhardwaj, A. Baassiri, R. K. Sundaram +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  9. Proton FLASH radiotherapy enhances control of triple-negative breast cancer through STING-IRF3 and CD8+ T-cell immunity
    P. Loap, I. Paraskevaidis, C. Cheptea +14
    bioRxivPreprintCC BYFull textOncologybioRxiv
  10. Merkel Cell Carcinoma Masquerading as Dermatitis.
    Marlena Freeman, Gregory Gates, Iris Ahronowitz
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  11. The EF1α promoter of cilta-cel drives a highly effective GZMK⁺ transcriptional program.
    Kevin Herrera, Sneha Mitra, Yuqing Sun +13
    Nature communicationsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  12. Return to Work After Adjuvant Chemotherapy for Colon Cancer: A Retrospective Study With Exploratory Occupational Analysis.
    Vanessa Duarte Branco, Francisca Liz, Marta Orey +6
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  13. Oral Kaposi Sarcoma With Clinical Features Suggestive of Concurrent Multicentric Castleman Disease in Advanced AIDS.
    Jamil Qiqieh, Imeelda Altone, Kareem Siada +2
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  14. Weighing the Odds: Body Mass Index and Recurrence-Free Survival in Early-Onset Colorectal Cancer
    E. Delryd, A. Tran, E. Bexe Lindskog +1
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  15. SARS-CoV-2 ORF8 Exploits Host miRNA Networks to Rewire Post-Transcriptional Regulation
    Raúl Fernández-Rodríguez, José M. Suárez-Cárdenas, Antonio Romero-Guillén +8
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  16. Cellular Plasticity and EMT in Cancer and Fibrotic Diseases
    Margherita Sisto, Sabrina Lisi
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  17. Tumor-Informed ddPCR for Personalized Longitudinal ctDNA Monitoring in Advanced Solid Tumors: Molecular–Radiological Concordance and Molecular Lead Time
    Dadasaheb Akolkar, Sneha Puranik, Sachin Apurwa +13
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  18. HLA-II Expression Marks Activated and Clonally Expanded CD8+ T Cells and Improves Tumor-Reactivity Prediction Across Human Cancers
    Xue Mi, Jinghua Zhu, Zhu Dai +4
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  19. Nuclear SOX9 Expression and Short-Term Survival Outcomes in Early-Stage Luminal Breast Cancer: An Immunohistochemical and Retrospective Cohort Analysis
    Ebru Karci, Sabin Goktas Aydin, Osman Erinc +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  20. MicroRNAs and Alarmins in Cardio-Oncology: Biomarkers and Therapeutic Implications in Skin and Breast Cancer
    Federica Cannistrà, Sara Sileno, Francesco Cribari +6
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  21. Fructose metabolism in pancreatic ductal adenocarcinoma: emerging vulnerabilities in KRAS G12D tumors and therapeutic perspectives with sodium citrate
    Philippe Icard, Alexandre Brinza, Stéphane Allouche +3
    Journal of experimental & clinical cancer researchPeer-reviewedCC BY 4.0Full textOncologyHAL
  22. Advancements and future directions in transformative therapies of prostate cancer
    Jinge Zhao, Bo Tang, Hao Zeng +1
    Chinese Medical JournalPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  23. Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells
    Dennis Roth, Rui P. L. Neves, Julia Geheb +15
    Molecular OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  24. The national standards for cancer survivorship care in action: caregiver experiences across stage, phase, and geography
    Abigayle R. Feather, Marguerite A. Webster, Marjorie L. Stanek +5
    Journal of Cancer SurvivorshipPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  25. Immunotherapy with Pembrolizumab beyond Progression and Local Ablative Therapy in Oligoprogressive Metastatic Non-Small Cell Lung Cancer
    Anton Oseledchyk, Leopold Häcker, Andreas Michael Schmitt +4
    Oncology Research and TreatmentPeer-reviewedCC BY-NC 4.0Full textOncologyPMC